To gain further knowledge on T‐cells in TP53‐mutated AML, we performed detailed transcriptomic analyses of specific T‐cell subpopulations from this patient group and compared to corresponding populations from healthy controls. This evidence concerns the gene TP53 and acute myeloid leukemia.